Mammalian pathogenesis of oseltamivir-resistant pandemic (H1N1) 2009 influenza virus isolated in South Korea

Mammalian pathogenesis of oseltamivir-resistant pandemic (H1N1) 2009 influenza virus isolated in... 1 Introduction</h5> Since the first report of pandemic influenza A(H1N1) 2009 (H1N1pdm09) virus in April 2009, the virus has spread worldwide and caused a pandemic in the 21st century ( Dawood et al., 2009 ). Anti-influenza agents have been widely used for the chemoprophylaxis and treatment during the 2009 H1N1 pandemic. Due to natural resistance of H1N1pdm09 viruses against adamantanes, neuraminidase (NA) inhibitors (NAIs), especially oseltamivir, were broadly used to mitigate morbidity and mortality during the early phase of the pandemic. With the increasing use of antivirals, oseltamivir-resistant mutants emerged rapidly and 11 cases of resistant viruses were detected during the H1N1 pandemic in South Korea ( Shin et al., 2011; Yi et al., 2010 ). The oseltamivir-resistant viral infections were observed mainly in immunocompromised patients treated with antivirals and all the NAI-resistant variants to H1N1pdm09 viruses had H275Y (N1 numbering) substitution at NA gene ( Yi et al., 2010 ).</P>To assess the fitness and transmissibility of the newly identified H1N1pdm09 virus, various mammalian models have been used and the results were similar or different depending on the viruses used ( Itoh et al., 2009; Kwon et al., 2010; Lange et al., 2009; Maines et al., 2009; Munster http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Virus Research Elsevier

Mammalian pathogenesis of oseltamivir-resistant pandemic (H1N1) 2009 influenza virus isolated in South Korea

Loading next page...
 
/lp/elsevier/mammalian-pathogenesis-of-oseltamivir-resistant-pandemic-h1n1-2009-Qz3TJ7fh0W
Publisher
Elsevier
Copyright
Copyright © 2014 Elsevier B.V.
ISSN
0168-1702
D.O.I.
10.1016/j.virusres.2014.03.014
Publisher site
See Article on Publisher Site

Abstract

1 Introduction</h5> Since the first report of pandemic influenza A(H1N1) 2009 (H1N1pdm09) virus in April 2009, the virus has spread worldwide and caused a pandemic in the 21st century ( Dawood et al., 2009 ). Anti-influenza agents have been widely used for the chemoprophylaxis and treatment during the 2009 H1N1 pandemic. Due to natural resistance of H1N1pdm09 viruses against adamantanes, neuraminidase (NA) inhibitors (NAIs), especially oseltamivir, were broadly used to mitigate morbidity and mortality during the early phase of the pandemic. With the increasing use of antivirals, oseltamivir-resistant mutants emerged rapidly and 11 cases of resistant viruses were detected during the H1N1 pandemic in South Korea ( Shin et al., 2011; Yi et al., 2010 ). The oseltamivir-resistant viral infections were observed mainly in immunocompromised patients treated with antivirals and all the NAI-resistant variants to H1N1pdm09 viruses had H275Y (N1 numbering) substitution at NA gene ( Yi et al., 2010 ).</P>To assess the fitness and transmissibility of the newly identified H1N1pdm09 virus, various mammalian models have been used and the results were similar or different depending on the viruses used ( Itoh et al., 2009; Kwon et al., 2010; Lange et al., 2009; Maines et al., 2009; Munster

Journal

Virus ResearchElsevier

Published: Jun 24, 2014

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off